Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 18
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Respiratory syncytial virus–related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE‑GAL study

  • Manzanares, Ángela
  • Pardo Seco, Jacobo José
  • Rivero Calle, Irene
  • Dacosta Urbieta, Ana Isabel
  • Mallah, Narmeen
  • Rodríguez-Tenreiro Sánchez, Carmen
  • Salas Ellacuriaga, Antonio
  • Martinón Torres, Federico
As part of the NIRSEGAL study (https://www.nirsegal.es/en), we present the clinical characteristics and course of respiratory syncytial virus (RSV)-related low respiratory tract infection (LRTI) hospitalizations in infants eligible for nirsevimab administration during the 2023–2024 season. Infants eligible for nirsevimab immunization (born between 1 April, 2023, and 30 March, 2024) who were hospitalized due to RSV-related LRTI between September 25, 2023, and April 15, 2024, in a hospital from the Galician Public Health system were included. Clinical and demographic characteristics of RSV-related LRTI hospitalizations were analyzed, with comparisons made between breakthrough cases (those immunized with nirsevimab) and non-breakthrough cases. During the study period, 69 RSV-related LRTI hospitalizations were recorded, with a median hospital stay of 4 (interquartile range (IQR) 3–6) days; 65.2% (N=45) were breakthrough cases. The median age was 2.7 (IQR 1.5–5.2) months, and more than half of them (N=39, 56.5%) were male. The incidence of cases was parallel to the RSV epidemic curve, suggesting no waning of nirsevimab efcacy. Of the total hospitalizations, 16 infants (23.2%) had a high-risk condition, 44 (63.8%) needed oxygen support, 15 (21.7%) were admitted to the intensive care unit (ICU), and 11 (15.9%) received non-invasive mechanical ventilation (NIMV). No statistically signifcant diferences were observed in these characteristics when comparing breakthrough and non-breakthrough cases. Conclusion: In the nirsevimab era, a substantial proportion of children who were hospitalized for RSV-related LRTI needed oxygen support, NIMV, and ICU admission. Clinical characteristics, timing, and outcomes were comparable between breakthrough and non-breakthrough cases. Trial registration: The NIRSE-GAL study protocol was registered on ClinicalTrials.gov (NCT06180993).
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

GUANIN: an all-in-one GUi-driven analyzer for NanoString interactive normalization

  • Montoto Louzao, Julián
  • Gómez Carballa, Alberto
  • Bello, Xavier
  • Pardo Seco, Jacobo José
  • Camino Mera, Alba
  • Viz Lasheras, Sandra
  • Martín, Maria J.
  • Martinón Torres, Federico
  • Salas Ellacuriaga, Antonio
Most tools for normalizing NanoString gene expression data, apart from the default NanoString nCounter software, are R packages that focus on technical normalization and lack configurable parameters. However, content normalization is the most sensitive, experiment-specific, and relevant step to preprocess NanoString data. Currently this step requires the use of multiple tools and a deep understanding of data management by the researcher. We present GUANIN, a comprehensive normalization tool that integrates both new and well-established methods, offering a wide variety of options to introduce, filter, choose, and evaluate reference genes for content normalization. GUANIN allows the introduction of genes from an endogenous subset as reference genes, addressing housekeeping-related selection problems. It performs a specific and straightforward normalization approach for each experiment, using a wide variety of parameters with suggested default values. GUANIN provides a large number of informative output files that enable the iterative refinement of the normalization process. In terms of normalization, GUANIN matches or outperforms other available methods. Importantly, it allows researchers to interact comprehensively with the data preprocessing step without programming knowledge, thanks to its easy-to-use Graphical User Interface (GUI).
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

A Timeframe for SARS-CoV-2 Genomes: A Proof of Concept for Postmortem Interval Estimations

  • Pardo Seco, Jacobo José
  • Bello Paderne, Xabier
  • Gómez Carballa, Alberto
  • Martinón Torres, Federico
  • Salas Ellacuriaga, Antonio
Establishing the timeframe when a particular virus was circulating in a population could be useful in several areas of biomedical research, including microbiology and legal medicine. Using simulations, we demonstrate that the circulation timeframe of an unknown SARS-CoV-2 genome in a population (hereafter, estimated time of a queried genome [QG]; tE-QG) can be easily predicted using a phylogenetic model based on a robust reference genome database of the virus, and information on their sampling dates. We evaluate several phylogeny-based approaches, including modeling evolutionary (substitution) rates of the SARS-CoV-2 genome (~10−3 substitutions/nucleotide/year) and the mutational (substitutions) differences separating the QGs from the reference genomes (RGs) in the database. Owing to the mutational characteristics of the virus, the present Viral Molecular Clock Dating (VMCD) method covers timeframes going backwards from about a month in the past. The method has very low errors associated to the tE-QG estimates and narrow intervals of tE-QG, both ranging from a few days to a few weeks regardless of the mathematical model used. The SARS-CoV-2 model represents a proof of concept that can be extrapolated to any other microorganism, provided that a robust genome sequence database is available. Besides obvious applications in epidemiology and microbiology investigations, there are several contexts in forensic casework where estimating tE-QG could be useful, including estimation of the postmortem intervals (PMI) and the dating of samples stored in hospital settings
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

DNA methylation signatures of severe RSV infection in infants: evidence from non-invasive saliva samples

  • Pischedda, Sara
  • Gómez Carballa, Alberto
  • Pardo Seco, Jacobo José
  • Viz Lasheras, Sandra
  • Camino Mera, Alma
  • Bello, Xabier
  • Currás Tuala, María José
  • Rivero Calle, I.
  • Dacosta Urbieta, A. I.
  • Martinón Torres, Federico
  • Salas Ellacuriaga, Antonio
  • GENDRES Consortium
Background: Respiratory syncytial virus (RSV) poses significant morbidity and mortality risks in childhood, particularly for previously healthy infants admitted to hospitals lacking predisposing risk factors for severe disease. This study aimed to investigate the role of the host epigenome in RSV infection severity using non-invasive buccal swabs from sixteen hospitalized infants admitted to the hospital for RSV infection. Eight patients had severe symptoms, and eight had mild to moderate symptoms. For DNA methylation analyses, the Illumina EPIC BeadChip was used with DNA isolated from saliva samples. To evaluate the basal DNA methylation level of the identified biomarkers a cohort of healthy control children was used. Furthermore, DNA methylation levels of candidate genes were confirmed by pyrosequencing in both the discovery and validation cohorts of patients with mild to moderate symptoms. Results: A panel of differentially methylated positions (DMPs) distinguishing severe from mild to moderate symptoms in infants was identified. DMPs were determined using a threshold of an adjusted P-value (false discovery rate, FDR) < 0.01 and an absolute difference in DNA methylation (delta beta) > 0.10. Differentially methylated regions (DMRs) were identified in the ZBTB38 (implicated in asthma and pulmonary disease) and the TRIM6-TRM34 gene region (associated with viral infections). The differential DNA methylation of these genes was validated in an independent replication cohort. A weighted correlation network analysis emphasized the pivotal role of a module with RAB11FIP5 as the hub gene, known for its critical function in regulating viral infections. Conclusions: Oral mucosa methylation may play a role in determining the severity of RSV disease in infants.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

Magnetically propelled chained nanocomposites for biologically relevant media exploration

  • Ramos Docampo, Miguel Alexandre
  • Hurtado, Pablo
  • Davila Ibañez, Ana Belen
  • Piñeiro, Roberto
  • López Fanarraga, Mónica
  • Salgueiriño Maceira, Verónica
Financiado para publicación en acceso aberto: Universidade de Vigo/CISUG, Elongated nanostructures to be remotely and magnetically propelled in biologically relevant media, have gained attention as offering themselves as effective tools or carriers in theragnostics applications. However, the magnetic actuation associated remains challenging due to the lack of mechanical information in the media of interest, taking into account biophysical or biomedical purposes. In this study, we detail the magnetic actuation of magnetically propelled chained nanocomposites considering their dynamics, in which their velocity can be modulated in terms of the viscosity of the medium considered, given a magnetic field gradient. Simpler cases of distilled water, a water/glycerol mixture and a fluid made of cell extracts (imitating the cytosol of cells) of known viscosity are the basis experiments for the study of more complex media inside HeLa cells, murine NIH-3T3 fibroblasts and zebrafish larvae, offering the mechanical information required. The experimental results indicate that the magnetically propelled performance of the chained nanostructures can be precisely controlled in potentially changing scenarios, where drug and heat delivery, magnetic separation, or microfluidic technologies are demanded, using a magnetic field gradient and providing good estimations of the dynamical parameters involved., Xunta de Galicia | Ref. ED481A/322, Xunta de Galicia | Ref. IN606A-2018/019, Xunta de Galicia | Ref. IN853B 2018/03, Ministerio de Economía y Competitividad | Ref. PI16/00496, Instituto de Salud Carlos III | Ref. PI19/00349, Instituto de Salud Carlos III | Ref. DTS19/00033, Agencia Estatal de Investigación | Ref. MAT2016-81955-REDT, Agencia Estatal de Investigación | Ref. PID2020-119242-I00
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

A custom-made functionalization method to control the biological identity of nanomaterials

  • Padín González, Esperanza
  • Navarro Palomares, Elena
  • Valdivia B., Lourdes
  • Iturrioz Rodríguez, Nerea
  • Correa Duarte, Miguel Ángel
  • Valiente, Rafael
  • Fanarraga, Mónica L.
Here we propose a one-step strategy to endow nanomaterials with a custom-designed bio-identity. This study designs a universal ‘nanomaterial binding domain’ that can be genetically attached to any protein ensuring precise and spontaneous protein orientation. We demonstrate how, despite the simplicity of the method, the bioconjugation achieved: (i) is highly efficient, even in the presence of competing proteins, (ii) is stable at extreme physiological conditions (pH ranges 5.2-9.0; NaCl concentrations 0-1 M); (iii) prevents unwanted protein biofouling days after incubation in biologically-relevant conditions; and finally, (iv) avoids nanoparticle interaction with promiscuous unspecific receptors. In summary, this protein biocoating technique, applicable to a wide array of nano-designs, integrates material science and molecular biology procedures to create hybrid nanodevices with well-defined surfaces and predictable biological behaviors, opening a chapter in precision nanodiagnostics, nanosensing or nanotherapeutic applications., Agencia Estatal de Investigación | Ref. MAT2016-81955-REDT, Instituto de Salud Carlos III | Ref. PI19/00349, Instituto de Salud Carlos III | Ref. DTS19/00033, Ministerio de Economía y Competitividad | Ref. CTM2014-58481-R, Agencia Estatal de Investigación | Ref. CTM2017-84050R, Agencia Estatal de Investigación | Ref. PGC 2018-101464-B-I00, Ministerio de Educación, Cultura y Deporte | Ref. FPU15/06881, Xunta de Galicia, Instituto de investigación sanitaria Valdecilla (Cantabria) | Ref. PREVAL16/02, Instituto de investigación sanitaria Valdecilla (Cantabria) | Ref. NNVAL17/11
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

GUANIN: an all-in-one GUi-driven analyzer for NanoString interactive normalization

  • Montoto Louzao, Julián
  • Gómez-Carballa, Alberto
  • Bello, Xabier
  • Pardo-Seco, Jacobo
  • Camino-Mera, Alba
  • Viz-Lasheras, Sandra
  • Martín, María J.
  • Martinon-Torres, Federico
  • Salas, Antonio
GUANIN can be installed with pip install GUANIN and it is available at https://pypi.org/project/guanin/. Source code, documentation, and case studies are available at https://github.com/julimontoto/guanin under the GPLv3 license., [Abstract]: Most tools for normalizing NanoString gene expression data, apart from the default NanoString nCounter software, are R packages that focus on technical normalization and lack configurable parameters. However, content normalization is the most sensitive, experiment-specific, and relevant step to preprocess NanoString data. Currently this step requires the use of multiple tools and a deep understanding of data management by the researcher. We present GUANIN, a comprehensive normalization tool that integrates both new and well-established methods, offering a wide variety of options to introduce, filter, choose, and evaluate reference genes for content normalization. GUANIN allows the introduction of genes from an endogenous subset as reference genes, addressing housekeeping-related selection problems. It performs a specific and straightforward normalization approach for each experiment, using a wide variety of parameters with suggested default values. GUANIN provides a large number of informative output files that enable the iterative refinement of the normalization process. In terms of normalization, GUANIN matches or outperforms other available methods. Importantly, it allows researchers to interact comprehensively with the data preprocessing step without programming knowledge, thanks to its easy-to-use Graphical User Interface (GUI)., The supercomputer FinisTerrae III and its permanent data storage system have been funded by the Spanish Ministry of Science and Innovation, the Galician Government, and the European Regional Development Fund (ERDF). This study also received support by (i) ISCIII: TRINEO: PI22/00162; DIAVIR: DTS19/00049; Resvi-Omics: PI19/01039 (A.S.), ReSVinext: PI16/01569, Enterogen: PI19/01090 (F.M.-T.), cofinanciados FEDER, (ii) GAIN: IN607B 2020/08 and IN607A 2023/02 (A.S.), GEN-COVID: IN845D 2020/23 (F.M.-T.), IIN607A2021/05 (F.M.-T.); (iii) ACIS: BI-BACVIR (PRIS-3, to A.S.), CovidPhy (SA 304 C, to A.S.); and (iv) consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CB21/06/00103; to A.S. and F.M.-T.). In addition, this study has been funded by ISCIII through the project “CP23/00080” and co-funded by the European Union. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication., Xunta de Galicia; IN607B 2020/08, Xunta de Galicia; IN607A 2023/02, Xunta de Galicia; IN845D 2020/23, Xunta de Galicia; IIN607A2021/05, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias; CB21/06/00103
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Tweak/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury

  • Guerrero-Hue, Melania
  • Vallejo-Mudarra, Mercedes
  • García-Caballero, Cristina
  • Córdoba-David, Gina Marcela
  • Palomino-Antolín, Alejandra
  • Herencia, Carmen
  • Vendrell-Casana, Beatriz
  • Rubio-Navarro, Alfonso
  • Egido, J.
  • Blanco-Colio, Luis M.
  • Moreno, Juan Antonio
Background Rhabdomyolysis is a severe clinical syndrome associated to acute kidney injury (AKI) and chronic kidney disease (CKD). TWEAK/Fn14 signaling axis regulates renal inflammation and tubular cell death. However, the functional role of TWEAK/Fn14 in rhabdomyolysis remains unknown. Methods Rhabdomyolysis was induced in wild-type, TWEAK- and Fn14-deficient mice or mice treated with TWEAK blocking antibody. Renal injury, inflammation, fibrosis and cell death were assessed. Additionally, we performed in vivo and in vitro studies to explore the possible signalling pathways involved in Fn14 regulation. Findings Fn14 renal expression was increased in mice with rhabdomyolysis, correlating with decline of renal function. Mechanistically, myoglobin (Mb) induced Fn14 expression via ERK and p38 pathway, whereas Nrf2 activation diminished Mb-mediated Fn14 upregulation in cultured renal cells. TWEAK or Fn14 genetic depletion ameliorated rhabdomyolysis-associated loss of renal function, histological damage, tubular cell death, inflammation, and expression of both tubular and endothelial injury markers. Deficiency of TWEAK or Fn14 also decreased long-term renal inflammation and fibrosis in mice with rhabdomyolysis. Finally, pharmacological treatment with a blocking TWEAK antibody diminished the expression of acute renal injury markers and cell death and lessened residual kidney fibrosis and chronic inflammation in rhabdomyolysis. Interpretation TWEAK/Fn14 axis participates in the pathogenesis of rhabdomyolysis-AKI and subsequent AKI-CKD transition. Blockade of this signaling pathway may represent a promising therapeutic strategy for reducing rhabdomyolysis-mediated renal injury.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A DNA Vaccine Delivery Platform Based on Elastin-Like Recombinamer Nanosystems for Rift Valley Fever Virus

  • Gonzalez-Valdivieso, Juan
  • Borrego, Belén
  • Girotti, Alessandra
  • Moreno, Sandra
  • Brun Torres, Alejandro
  • Bermejo-Martin, Jesús
  • Arias, F. Javier
13 Pág., This work analyzes the immunogenicity of six genetically engineered constructs based on elastin-like recombinamers (ELRs) fused to the Gn glycoprotein from Rift Valley fever virus (RVFV). Upon transfection, all constructs showed no effect on cell viability. While fusion constructs including ELR blocks containing hydrophobic amino acids (alanine or isoleucine) did not increase the expression of viral Gn in eukaryotic cells, glutamic acid- or valine-rich fusion proteins showed enhanced expression levels compared with the constructs encoding the viral antigen alone. However, in vivo DNA plasmid immunization assays determined that the more hydrophobic constructs reduced viremia levels after RVFV challenge to a higher extent than glutamic- or valine-rich encoding plasmids and were better inducers of cellular immunity as judged by in vitro restimulation experiments. Although the Gn-ELR fusion constructs did not surpass the protective efficacy of a plasmid vaccine expressing nonfused Gn, our results warrant further experiments directed to take advantage of the immunomodulatory potential of ELR biomaterials for improving vaccines against infectious diseases., The authors are grateful for financial support from the European Social Fund (ESF) and the European Regional Development Fund (ERDF), as well as funding from the EU (H2020-NMP-2014-646075), the MICIUN (DTS19/00162, MAT2016-79435-R, MAT2016-78903-R and AGL2017-82336-R), the Comunidad de Madrid (project S2018/BAA-4370) the JCyL (project VA317P18), the CIBER-BBN, the JCyL and the Instituto de Salud Carlos III under the “Network Center of Regenerative Medicine and Cellular Therapy of Castilla and Leon”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL

  • Lahera, Antonio
  • Vela-Martín, Laura
  • López-Nieva, P.
  • Salgado, Rocío N.
  • Rodríguez-Perales, Sandra
  • Torres-Ruiz, Raúl
  • López-Lorenzo, Jose L
  • Cornago, Javier
  • Llamas, Pilar
  • Fernández-Navarro, Pablo
  • Sánchez-Domínguez, Rebeca
  • Segovia, Jose C.
  • Sastre, Isabel
  • Cobos-Fernández, María
  • Menéndez, Pablo
  • Santos, Javier
  • Fernández-Piqueras, José
  • Villa-Morales, María
descripción no proporcionada por scopus, This work was supported in part by funds from Ministerio de Economía y Competitividad (SAF2015-70561-R; MINECO/FEDER, EU to J.F.-P. and M.V.-M.); Ministerio de Ciencia, Innovación y Universidades (RTI2018-093330-B-I00; MCIU/FEDER, EU to J.F.-P. and J.S.); Fundación Ramón Areces (CIVP19S7917 to J.F.-P.); Comunidad de Madrid (B2017/BMD-3778; LINFOMAS-CM to J.F.-P.); Asociación Española Contra el Cáncer (AECC, 2018; PROYE18054PIRI to J.F.-P. and LABAE20049RODR to S.R-P.); Spanish National Research and Development Plan, Instituto de Salud Carlos III and FEDER (PI20/01837 to S.R.-P. and PI21/01641 to R.T.-R.); Proyecto Desarrollo Tecnológico (DTS19/00111 to S.R.-P.); Instituto de Investigación Sanitaria Fundación Jiménez Díaz to J.F.-P. Institutional grants from the Fundación Ramón Areces and Banco de Santander to the CBMSO; IAP-DRCLAS at Harvard and Fundación Asisa (086812) are also acknowledged.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients

  • Parody-Rua, Elizabeth
  • Bustamante, Alejandro
  • Montaner, Joan
  • Rubio-Valera, María
  • Serrano, David
  • Pérez-Sánchez, Soledad
  • Sánchez-Viñas, Alba
  • Guevara-Cuellar, César
  • Serrano-Blanco, Antoni
© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/., [Objectives] Stroke treatment with intravenous tissue-type plasminogen activator (tPA) is effective and efficient, but as its benefits are highly time dependent, it is essential to treat the patient promptly after symptom onset. This study evaluates the cost-effectiveness of a blood biomarker test to differentiate ischemic and hemorrhagic stroke to guide pre-hospital treatment with tPA in patients with suspected stroke, compared with standard hospital management. The standard care for patients suffering stroke consists mainly in diagnosis, treatment, hospitalization and monitoring., [Methods] A Markov model was built with four health states according to the modified Rankin scale, in adult patients with suspected moderate to severe stroke (NIHSS 4-22) within 4.5 hours after symptom onset. A Spanish Health System perspective was used. The time horizon was 15 years. Quality-adjusted life-years (QALYs) and life-years gained (LYGs) were used as a measure of effectiveness. Short- and long-term direct health costs were included. Costs were expressed in Euros (2022). A discount rate of 3% was used. Probabilistic sensitivity analysis and several one-way sensitivity analyses were conducted., [Results] The use of a blood-test biomarker compared with standard care was associated with more QALYs (4.87 vs. 4.77), more LYGs (7.18 vs. 7.07), and greater costs (12,807€ vs. 12,713€). The ICER was 881€/QALY. Probabilistic sensitivity analysis showed that the biomarker test was cost-effective in 82% of iterations using a threshold of 24,000€/QALY., [Conclusions] The use of a blood biomarker test to guide pre-hospital thrombolysis is cost-effective compared with standard hospital care in patients with ischemic stroke., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The present study is part of the Instituto de Salud Carlos III (ISCIII) grant, file number PMP15/00022, and Biomarkers for Initiating Onsite and Faster Ambulance Stroke Therapies (BIOFAST) DTS19/00135. We thank the Research Network on Preventative Activities and Health Promotion (redIAPP) (RD16/0007/0012), the European Regional Development Fund, and the CIBERESP (Centro de Investigación Biomedica en Red de Epidemiología y Salud Pública, CB16/02/00322), for their support in study development. Dr. A. Serrano-Blanco has a personal grant from the PERIS program (SLT006/17/68), Generalitat de Catalunya (Spain), to partially dedicate his time to research during the study period. Dr. Rubio-Valera has a “Miguel Servet” research contract from ISCIII, Ministry of Economy and Competitiveness (Spain) (CP19/00029)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice

  • Opazo-Ríos, Lucas
  • Tejera-Muñoz, Antonio
  • Soto Catalan, Manuel
  • Marchant, Vanessa
  • Mas Fontao, Sebastián
  • Lavoz, Carolina
  • Moreno, Juan Antonio
  • Fierro Fernandez, Marta
  • Ramos, Ricardo
  • Suarez-Alvarez, Beatriz
  • López-Larrea, Carlos
  • Ruiz-Ortega, Marta
  • Egido, Jesús
  • Rodrigues-Díez, Raúl R.
Diabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the last few years, there still exists a high residual risk of disease progression to end-stage renal failure. To further understand the pathogenesis of tissue injury in this disease, by means of the Next-Generation Sequencing, we have studied the microRNA (miRNA) differential expression pattern in kidneys of Black and Tan Brachyury (BTBR) ob/ob (leptin deficiency mutation) mouse. This experimental model of type 2 diabetes and obesity recapitulates the key histopathological features described in advanced human DN and therefore can provide potential useful translational information. The miRNA-seq analysis, performed in the renal cortex of 22-week-old BTBR ob/ob mice, pointed out a set of 99 miRNAs significantly increased compared to non-diabetic, non-obese control mice of the same age, whereas no miRNAs were significantly decreased. Among them, miR-802, miR-34a, miR-132, miR-101a, and mir-379 were the most upregulated ones in diabetic kidneys. The in silico prediction of potential targets for the 99 miRNAs highlighted inflammatory and immune processes, as the most relevant pathways, emphasizing the importance of inflammation in the pathogenesis of kidney damage associated to diabetes. Other identified top canonical pathways were adipogenesis (related with ectopic fatty accumulation), necroptosis (an inflammatory and regulated form of cell death), and epithelial-to-mesenchymal transition, the latter supporting the importance of tubular cell phenotype changes in the pathogenesis of DN. These findings could facilitate a better understanding of this complex disease and potentially open new avenues for the design of novel therapeutic approaches to DN., This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union (PI17/ 00119, PI17/01495, PI17/00130, PI20/00140, PI19/00184, PI20/00639, PI20/00487, PI20/00375, DTS20/00083, and DTS19/00093), Red de Investigación Renal REDINREN: RD16/0009 to MR-O (RD16/0009/0003) and to CL-L (RD16/0009/0020), Sociedad Española de Nefrología, “NOVELREN-CM: Enfermedad renal crónica: nuevas Estrategias para la prevención, Diagnóstico y tratamiento” (B2017/BMD-3751 to MR-O), “Convocatoria Dinamización Europa Investigación 2019” MINECO (EIN 2019-103294 to MR-O), Innovation programme under the Marie SkłodowskaCurie grant of the European Union’s Horizon 2020 (IMProve-PD ID: 812699 to MR-O), Spanish Biomedical Research Centre in Cardiovascular Diseases (CIBERCV), Spanish Ministry of Science and Innovation (RYC-2017- 22369), Consejería de Salud y Familias-FEDER, Junta de Andalucía (PIGE-0052-2020 to JM), and Gobierno de Chile (S-2020-05 VIDCA-UACh to CL). RICORS program to RICORS2040 (KIDNEY DISEASE) RD21/0005/0002 to MRO; RD21/0005/0017 to CL-L.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Wearable Devices Based on Bioimpedance Test in Heart-Failure: Design Issues

  • Scagliusi, Santiago F.
  • Giménez-Miranda, L.
  • Pérez-García, Pablo
  • Olmo-Fernández, Alberto
  • Huertas-Sánchez, Gloria
  • Medrano Ortega, Francisco J.
  • Yúfera, Alberto
Heart-failure (HF) is a severe medical condition. Physicians need new tools to monitor the health status of their HF patients outside the hospital or medical supervision areas, to better know the evolution of their patients' main biomarker values, necessary to evaluate their health status. Bioimpedance (BI) represents a good technology for sensing physiological variables and processes on the human body. BI is a non-expensive and non-invasive technique for sensing a wide variety of physiological parameters, easy to be implemented on biomedical portable systems, also called "wearable devices". In this systematic review, we address the most important specifications of wearable devices based on BI used in HF real-time monitoring and how they must be designed and implemented from a practical and medical point of view. The following areas will be analyzed: the main applications of BI in heart failure, the sensing technique and impedance specifications to be met, the electrode selection, portability of wearable devices: size and weight (and comfort), the communication requests and the power consumption (autonomy). The different approaches followed by biomedical engineering and clinical teams at bibliography will be described and summarized in the paper, together with results derived from the projects and the main challenges found today., LCF/TR/CI22/52660013/ La Caixa Banking Foundation DTS19/00134/ “Real-Time Monitoring Prognostic Value of Volume With BI Test in Patients With Acute HF (HEART-FAIL VOLUM)” DTS19/00137/ “Real-Time Monitoring Prognostic Value of Volume With BI Test in Patients With Acute HF (HEART-FAIL VOLUM)”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Assessing Cognitive Workload in Motor Decision-Making through Functional Connectivity Analysis: Towards Early Detection and Monitoring of Neurodegenerative Diseases

  • Cano, Leonardo Ariel
  • Albarracín, Ana Lía
  • Pizá, Alvaro Gabriel
  • García-Cena, Cecilia
  • Fernández-Jover, Eduardo
  • Farfán, Fernando Daniel
This article belongs to the Special Issue Biomedical Sensors for Diagnosis and Rehabilitation., Neurodegenerative diseases (NDs), such as Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, and frontotemporal dementia, among others, are increasingly prevalent in the global population. The clinical diagnosis of these NDs is based on the detection and characterization of motor and non-motor symptoms. However, when these diagnoses are made, the subjects are often in advanced stages where neuromuscular alterations are frequently irreversible. In this context, we propose a methodology to evaluate the cognitive workload (CWL) of motor tasks involving decision-making processes. CWL is a concept widely used to address the balance between task demand and the subject's available resources to complete that task. In this study, multiple models for motor planning during a motor decision-making task were developed by recording EEG and EMG signals in n=17 healthy volunteers (9 males, 8 females, age 28.66±8.8 years). In the proposed test, volunteers have to make decisions about which hand should be moved based on the onset of a visual stimulus. We computed functional connectivity between the cortex and muscles, as well as among muscles using both corticomuscular and intermuscular coherence. Despite three models being generated, just one of them had strong performance. The results showed two types of motor decision-making processes depending on the hand to move. Moreover, the central processing of decision-making for the left hand movement can be accurately estimated using behavioral measures such as planning time combined with peripheral recordings like EMG signals. The models provided in this study could be considered as a methodological foundation to detect neuromuscular alterations in asymptomatic patients, as well as to monitor the process of a degenerative disease., This research was partially supported by the Grant RESOL-1225-APN-DIR#CONICET from the Argentinian “Consejo Nacional de Investigaciones Científicas y Técnicas” (CONICET) and the Argentinian “Instituto Superior de Investigaciones Biológicas” (INSIBIO), as well as Grants RTI2018-098969-B-I00, DTS19/00175, and PDC2022-133952-100 from the Spanish “Ministerio de Ciencia, Innovación y Universidades” and by the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No. 899287 (NeuraViPeR). The APC was partially funded by PIUNT E701 from the Argentinian “Universidad Nacional de Tucumán” (UNT)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells

  • Martinez-Lage , Marta|||0000-0001-5535-025X
  • Torres, Raul|||0000-0001-9606-0398
  • Puig-Serra, Pilar|||0000-0002-7802-4972
  • Moreno-Gaona, Patricia
  • Martin, M. Carmen
  • Moya, Francisco J.
  • Quintana-Bustamante, Oscar|||0000-0002-6869-7006
  • Garcia-Silva, Susana|||0000-0003-1065-0245
  • Carcaboso, Angel M.|||0000-0002-8485-426X
  • Petazzi, Paolo|||0000-0002-1036-2895
  • Bueno, Clara|||0000-0003-1442-6216
  • Català-Mora, Jaume|||0000-0003-2152-8579
  • Peinado, Héctor|||0000-0002-4256-3413
  • Segovia, Jose C.|||0000-0003-4101-6124
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
  • Rodriguez-Perales, Sandra|||0000-0001-7221-3636
Fusion oncogenes (FOs) are common in many cancer types and are powerful drivers of tumor development. Because their expression is exclusive to cancer cells and their elimination induces cell apoptosis in FO-driven cancers, FOs are attractive therapeutic targets. However, specifically targeting the resulting chimeric products is challenging. Based on CRISPR/Cas9 technology, here we devise a simple, efficient and non-patient-specific gene-editing strategy through targeting of two introns of the genes involved in the rearrangement, allowing for robust disruption of the FO specifically in cancer cells. As a proof-of-concept of its potential, we demonstrate the efficacy of intron-based targeting of transcription factors or tyrosine kinase FOs in reducing tumor burden/mortality in in vivo models. The FO targeting approach presented here might open new horizons for the selective elimination of cancer cells.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The insecticides permethrin and chlorpyrifos show limited genotoxicity and no leukemogenic potential in human and murine hematopoietic stem progenitor cells

  • Rodriguez-Cortez, Virginia C.
  • Navarrete-Meneses, Maria Pilar
  • Molina, Oscar|||0000-0001-7585-4519
  • Velasco-Hernández, Talia|||0000-0003-2183-7443
  • González, Jéssica
  • Romecín, Paola Alejandra|||0000-0001-6890-5883
  • Gutiérrez-Agüera, Francisco|||0000-0002-8620-2839
  • Roca Ho, Heleia|||0000-0001-7324-5234
  • Vinyoles, Meritxell|||0000-0003-1906-4701
  • Kowarz, Eric
  • Marin, Pedro
  • Rodriguez-Perales, Sandra|||0000-0001-7221-3636
  • Gomez-Marin, Carlos
  • Perez-Vera, Patricia
  • Cortes-Ledesma, Felipe
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Terron, Andrea
  • Bueno, Clara|||0000-0003-1442-6216
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL

  • Lahera, Antonio|||0000-0002-8899-1376
  • Vela Martín, Laura|||0000-0001-9435-8668
  • López Nieva, Pilar|||0000-0001-6369-2444
  • Salgado Sánchez, Rocío Nieves|||0000-0003-1678-8982
  • Rodriguez-Perales, Sandra|||0000-0001-7221-3636
  • Torres-Ruiz, Rocío
  • López Lorenzo, José L.|||0000-0003-1502-3902
  • Cornago, Javier|||0000-0002-0737-4211
  • Llamas, Pilar
  • Fernández-Navarro, Pablo|||0000-0001-9427-2581
  • Sánchez Domínguez, Rebeca
  • Segovia, Jose C.|||0000-0003-4101-6124
  • Sastre, Isabel
  • Cobos Fernández, María Á.
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
  • Santos Hernández, Javier|||0000-0002-4168-6251
  • Fernández Piqueras, José
  • Villa Morales, María
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Multimodal minimally invasive wearable technology for epilepsy monitoring: a feasibility study of the periauricular area

  • Besné, Guillermo M.
  • Iturri López, Peio
  • Alegre, Manuel
  • Artieda, Julio
  • Trigo Vilaseca, Jesús Daniel
  • Serrano Arriezu, Luis Javier
  • Falcone Lanas, Francisco
  • Valencia Ustárroz, Miguel
Ambulatory monitoring is of great interest in both clinical and domestic environments. Despite the technological advances, few monitoring solutions are suitable for medical application and diagnosis. Here, we investigate the feasibility of targeting the periauricular area (ear pavilion, ear canal, and the surrounding skin areas) to implement a multimodal system that fulfills the requirements of ergonomics and minimal obstructiveness in the context of epilepsy monitoring. Six physiological signals are selected and explored for their integration in the area of interest and a ¿proof-of-concept¿ prototype integrating the components in a single portable device targeting the selected location is implemented. Results show mixed results where some parameters are highly reliable, and others are impractical or require customized technology to provide clinically relevant information. To enable data acquisition, storage, and processing within the Internet of Medical Things paradigms, wireless body area transceiver integration is also analyzed in terms of coverage/capacity relations, showing feasibility for such device configuration., This work was supported in part by the Department of Economic Development of the Government of Navarra under Grant GN 2019 PC078-079; in part by the Carlos III Health Institute through the project under Grant DTS19/00130 (co-financed by the European Regional Development Fund; “A way to make Europe”); and in part by the Agencia Estatal de Investigación, Fondo Europeo de Desarrollo Regional -FEDER-, European Union under Grant PID2021-127409OB-C31 CONDOR.